← Back
$MAZE All transactions

Maze Therapeutics, Inc.

A

$ Value

$0

Shares

100,000

Price

$0

Filed

Sep 24

Insider

Name

Coloma Jason V

Title

Chief Executive Officer

CIK

0001676170

Roles

Director Officer

Transaction Details

Transaction Date

2025-09-22

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

100,000

Footnotes

Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. | The award shall vest as to 1/2 of the total award on September 1, 2026 and September 1, 2027, subject to the reporting person's continued service to the Issuer on each vesting date. | These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

Filing Info

Accession No.

0001676170-25-000008

Form Type

4

Issuer CIK

0001842295

Coloma Jason V's History

Date Ticker Type Value
2025-09-22 MAZE A $0

Other Insiders at MAZE (90d)

Insider Bought Sold Last
Kumar Neil 2026-03-27
Dandekar Atul
CSBO
$220K 2026-03-30
Bernstein Harold
President, R&D & CMO
$442K 2026-04-01
Bachrodt Amy
SVP, Finance
$74K 2026-04-01